News Grower

Independent coverage of AI, startups, and technology.

Ars Technica Jun 15, 2026 at 21:04 Big Tech Rising Hot

COVID vaccines still protect against heart problems, large study finds

Despite continued benefits, anti-vaccine rhetoric has driven down vaccination.

Signal weather

Rising

Momentum is building quickly, so this card is a good early entry point into the topic.

By Beth Mole Original source
COVID vaccines still protect against heart problems, large study finds

Although most Americans have eschewed seasonal COVID-19 vaccines, the updated shots continue to show significant protection against cardiovascular disease, especially for those over age 75 and those with underlying medical conditions. That's according to a new study that pulled data from more than 1 million patients in a US Department of Veterans Affairs (VA) health system. The finding builds on previous data showing that the vaccines significantly lower the risk of COVID-19-associated cardiovascular risks, particularly heart attacks and strokes. But it wasn't a given that the benefit would hold up over time—as the virus evolved, the vaccines were updated, population-level immunity increased from previous infection and vaccination, and risk of severe outcomes fell. The new study, published in JAMA Internal Medicine, found that the 2024–2025 COVID-19 vaccine continued to protect against COVID-19-associated "major adverse cardiovascular events" (MACE), which include cardiovascular death, heart attack, stroke, and hospitalization for heart failure. Read full article Comments

Stay on the signal

Follow COVID vaccines still protect against heart problems, large study finds

Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.

We send a confirmation link first, then only meaningful digests.

Story map

Understand this topic fast

A quick entry into the story: why it matters now, who is involved, and where to go next for context.

Why it matters now

Fresh coverage with immediate momentum.
There are already 6 connected articles in the same storyline to continue from here.
The story keeps orbiting around Anti Vaccine, Anti Vaccine Rhetoric, and Ars Technica, so the entity pages are the fastest way to build context.
Ars Technica already has 4 follow-up stories on the same theme.

Topic constellation

Open the live map for this story

See which entities, story threads, sources, and follow-up articles shape this story right now.

Click nodes to continue

Entity Cluster Article Hub Source

Story timeline

Continue with this story

A short sequence of events and follow-up stories to understand the arc quickly.

Jun 15, 2026 at 21:04 Ars Technica

COVID vaccines still protect against heart problems, large study finds

Despite continued benefits, anti-vaccine rhetoric has driven down vaccination.

Jun 15, 2026 at 19:07 Ars Technica

Chipmaker Nvidia seeks to raise over $25B in first bond deal since 2021

Debt sale set to test investor appetite for further exposure to AI sector amid a deluge of borrowing.

Jun 15, 2026 at 18:55 Ars Technica

A Chinese rocket breaks apart dangerously close to the Starlink constellation

The rocket's breakup likely generated 100 to 150 new pieces of space junk.

Jun 15, 2026 at 18:29 Ars Technica

Fox’s $22B Roku acquisition aims to expand its reach into smart TVs, advertising

Fox plans to take over Roku's streaming hardware, OS, and FAST services.

Jun 15, 2026 at 17:55 Ars Technica

Users cry foul after AMD stripped memory crypto from its consumer CPUs

AMD's stripping of TSME from consumer CPUs appears to be a deliberate, covert move.

Jun 15, 2026 at 16:32 Ars Technica

20 years of Intel Macs: Why Apple switched, and why it switched again

Remembering the ups and downs of the Intel Mac era as it finally winds down.

How reliable this looks

Signal and trust for Ars Technica

This source works at a rapid pace: 100% of recent stories land in the hot window, and 0% carry visible search signal.

Trusted

Reliability

92

Freshness

100

Sources in storyline

1

Related articles

More stories that share tags, source, or category context.

More from Ars Technica

Fresh reporting and follow-up coverage from the same newsroom.

Open source page